openPR Logo
Press release

The long-acting drug delivery technologies market is projected to grow at a CAGR of 13.6%, till 2035, claims Roots Analysis

08-20-2025 07:43 AM CET | Health & Medicine

Press release from: Roots Analysis

The long-acting drug delivery technologies market is projected

The growing concern of patient non-compliance and poor adherence to conventional medication regimen has prompted various biopharmaceutical companies to leverage the expertise of players offering long-acting drug delivery technologies and services

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/long-acting-drug-delivery-market/request-quote.html

Roots Analysis is pleased to announce the publication of its recent study, titled, "Long-Acting Drug Delivery Technologies and Services Market, 2023-2035"

The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes

1. An executive summary of the insights captured during our research. It offers a high-level view on the current state of long-acting drug delivery technologies and services market and its likely evolution in the mid-long term.
2. A general overview of long-acting drug delivery and the different types of long-acting drug delivery systems. Additionally, it highlights the underlying principles and strategies associated with long-acting drug delivery.
3. A detailed assessment of the current technology landscape of long-acting drug delivery technologies.
4. A detailed assessment of the overall service providers landscape of the companies offering contract services related to long-acting drug delivery.
5. A technology competitiveness analysis of long-acting drug delivery technologies.
6. A company competitiveness analysis of long-acting drug delivery service providers.
7. Elaborate profiles of prominent players developing technologies and offering services in the domain of long-acting drug delivery (shortlisted based on a proprietary criterion).
8. A detailed analysis of the recent partnerships inked between stakeholders engaged in this domain, since 2018.
9. A detailed analysis of over 570 peer-reviewed, scientific articles focused on research related to long-acting drug delivery.
10. An in-depth analysis of various patents that have been filed / granted related to long-acting drug delivery, since 2018.
11. A detailed review of academic grants that have been awarded to various research institutes for projects focused on long-acting drug delivery, since 2018.
12. A detailed market forecast, featuring analysis of the current and projected future opportunity across

Key market segments (listed below)

Principle
1. Manipulation of drug release from delivery systems
2. Manipulation of in vivo clearance

Strategy
1. Chemical Modification
2. Micro-encapsulation
3. Long-Acting Hydrogels
4. Long-Acting Implants
5. Long-Acting Microneedles
6. Multivesicular Liposomes
7. Nanocrystal Suspensions
8. Protein Fusion

Compatible Dosage Form
1. Injectables
2. Implantables
3. Oral Dosage Forms
4. Topical / Transdermal Dosage Forms
5. Vaginal Dosage Forms
6. Other Dosage Forms

Type of Molecules Delivered
1. Small Molecules
2. Biologics
3. Other Molecules

Type of Material Used
1. Polymer based
2. Non-polymer based

Key Geographical Regions
1. North America
2. Europe
3. Asia-Pacific
4. Middle East and North Africa

To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/reports/long-acting-drug-delivery-market/request-sample.html

Key companies covered in the report
1. Adare Pharma Solutions
2. AMW
3. Bostal Drug Delivery
4. Creative Biolabs
5. ForDoz Pharma
6. Innocore Pharmaceuticals
7. Integral BioSystems
8. LATITUDE Pharmaceuticals
9. Navin Saxena Research and Technology Centre (NSRT)
10. Samyang Biopharm

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/long-acting-drug-delivery-market.html

Contact Details
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The long-acting drug delivery technologies market is projected to grow at a CAGR of 13.6%, till 2035, claims Roots Analysis here

News-ID: 4151162 • Views:

More Releases from Roots Analysis

Respiratory syncytial virus infections are recognized among the prevalent respiratory diseases, accounting for approximately 33 million new cases in children aged under five years, annually
Respiratory syncytial virus infections are recognized among the prevalent respir …
Currently, several traditional techniques are available for treating these infections, although none of them have been competent enough to reduce the healthcare burden of RSV diseases. In order to address this, RSV vaccines emerged as a promising alternative, which provides active immunity against the RSV infections, thus protecting the vulnerable population. Further, by providing targeted immunity, these vaccines help reducing the severity of RSV infections and lower the hospitalization rates
Rise in demand of glp-1 drugs for metabolic disorders.
Rise in demand of glp-1 drugs for metabolic disorders.
In recent years, owing to its broader clinical potential in the treatment of obesity and type 2 diabetes, along with their proven efficacy in reducing cardiovascular risks, GLP-1 drugs market has garnered significant traction within the medical science domain. Concurrently, the rising demand and escalating prevalence of metabolic disorder including type 2 diabetes and obesity are fueling the need for treatments capable of effectively managing these conditions. This trend is expected
Carbon footprint management market is Set to Soar to USD 55.9 Billion by 2035
Carbon footprint management market is Set to Soar to USD 55.9 Billion by 2035
Carbon footprint refers to the measurement of greenhouse gas emissions, expressed in carbon dioxide equivalent. It is released into the atmosphere either directly or indirectly through various activities, processes, or products. These emissions originate from diverse sources, including energy consumption, manufacturing processes, transportation networks, and waste management strategies. The global carbon footprint management market, valued at USD 12.2 billion in 2024, is expected to reach USD 13.5 billion in 2025
Gene switches have garnered significant attention from drug developers owing to their ability to control the activity of genetically modified cell products in vivo
Gene switches have garnered significant attention from drug developers owing to …
The global gene switch market size is estimated to grow from USD 795 million in 2025 to USD 2,478 million by 2035, representing a CAGR of 12.03% during the forecast period till 2035. Driven by numerous developmental breakthroughs and encouraging study results demonstrating the vast potential of adoptive cell therapies (ACT), including CAR-T cell therapies, TCR therapies, TILs and natural killer cell therapies, in the treatment of various complex disorders, this

All 5 Releases


More Releases for Dosage

Oral Solid Dosage Pharmaceutical Formulation: Critical Driver Shaping the Chroni …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Oral Solid Dosage Pharmaceutical Formulation Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market for oral solid dosage pharmaceutical formulations has seen robust growth in the last few years. Its size is expected to increase from $618.34 billion in 2024 to $653.26 billion in
Cordyceps Sinensis Market : Benefits, Side Effects, Dosage, and Interactions
Cordyceps sinensis is a type of fungus that has been used in traditional herbal medicine for centuries. It increases the efficiency of the circulatory system, and these factors are expected to increase the demand for Cordyceps sinensis in the healthcare industry. Hence, the use of this is increasing consequently, leading the market growth. Market Development •In November 2021, Peaceful Harvest Mushrooms, a certified organic grower in the United States, released whole dried
Oral Solid Dosage Market Witness High Demand During by 2030
A recent market research report added to repository of Analytics Market Research is an in-depth analysis of Global & USA Oral Solid Dosage Market. On the basis of historic growth analysis and current scenario of Oral Solid Dosage market place, the report intends to offer actionable insights on Global & USA market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights
Pharmaceutical Solid Dosage Contract Manufacturing Market 2021 | Detailed Report
The Pharmaceutical Solid Dosage Contract Manufacturing market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Pharmaceutical Solid Dosage Contract Manufacturing report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period. The Pharmaceutical Solid Dosage Contract Manufacturing research
Dosage Spoon Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Dosage Spoon Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Dosage Spoon players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Dosage Spoon with respect to individual growth
Tiamulin Market By Dosage Form Powder and Injectable
Tiamulin aids in treatment and prophylaxis of several diseases such as dysentery, pneumonia, and mycoplasmal infections in pigs and poultry. Increasing demand for pork and poultry meat along with increase in pig farming and poultry is expected to propel demand for antibiotic drug tiamulin and fuel global tiamulin market growth. This is owing to the susceptibility of pigs and poultry animals to various types of infections and diseases. According to